Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E And Apolipoprotein E Receptors Modulate Aβ-induced Glial Neuroinflammatory Responses

M. LaDu, J. A. Shah, C. Reardon, G. Getz, G. Bu, Jingru Hu, Ling-yan Guo, L. J. Eldik
Published 2001 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Large numbers of activated glia are a common pathological feature of many neurodegenerative disorders, including Alzheimer's disease (AD). Several different stimuli, including lipopolysaccharide (LPS), dibutyryl (db)cAMP, and aged amyloid-beta 1-42 (A beta), can induce glial activation in vitro, as measured by morphological changes and the production of pro-inflammatory cytokines and oxidative stress molecules. Only A beta-induced activation is attenuated by the addition of exogenous apolipoprotein E (apoE)-containing particles. In addition, only A beta also induces an increase in the amount of endogenous apoE, the primary apolipoprotein expressed by astrocytes in the brain. The functional significance of the increase in apoE appears to be to limit the inflammatory response. Indeed, compared to wild type mice, glial cells cultured from apoE knockout mice exhibit an enhanced production of several pro-inflammatory markers in response to treatment with A beta and other activating stimuli. The mechanism for both the A beta-induced glial activation and the increase in apoE appears to involve apoE receptors, a variety of which are expressed by both neurons and glia. Experiments using receptor associated protein (RAP), an inhibitor of apoE receptors with a differential affinity for the low-density lipoprotein receptor (LDLR) and the LDLR-related protein (LRP), revealed that LRP mediates A beta-induced glial activation, while LDLR mediates the A beta-induced changes in apoE levels. In summary, both an apoE receptor agonist (apoE) and an antagonist (RAP) inhibit A beta-induced glial cell activation. Thus, apoE receptors appear to translate the presence of extracellular A beta into cellular responses, both initiating glial cell activation and limiting its scope by inducing apoE, an anti-inflammatory agent.
This paper references
10.1073/PNAS.83.4.1125
Expression of apolipoprotein E during nerve degeneration and regeneration.
M. Ignatius (1986)
10.1016/s0021-9258(18)47945-8
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.
R. E. Pitas (1987)
10.1016/0006-8993(91)91092-F
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
Y. Namba (1991)
10.1016/0304-3940(92)90444-C
Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
T. Wisniewski (1992)
10.1006/BBRC.1993.1423
Apolipoprotein E : binding to soluble Alzheimer's β-amyloid
T. Wisniewski (1993)
10.1073/PNAS.90.5.1977
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
G. W. Rebeck (1993)
10.1042/BJ2930027
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
J. Ghiso (1993)
10.1042/BJ2960867
Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
S. P. Iadonato (1993)
Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
T. Wisniewski (1993)
10.1146/ANNUREV.BI.63.070194.003125
Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).
M. Krieger (1994)
Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues.
M. Kounnas (1994)
Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.
J. Ma (1994)
Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons.
G. Bu (1994)
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.
J. Whitson (1994)
10.1172/JCI117407
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
D. A. Sanan (1994)
10.1006/BBRC.1994.1209
Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E
J. Whitson (1994)
Isoform-specific binding of apolipoprotein E to beta-amyloid.
M. LaDu (1994)
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
T. Wisniewski (1994)
10.1038/372092A0
Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
J. Ma (1994)
10.1074/JBC.270.13.7563
Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction (*)
E. Matsubara (1995)
10.1002/ANA.410370212
Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein
G. Rebeck (1995)
10.1074/JBC.270.2.536
The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors (*)
J. Medh (1995)
10.1073/PNAS.92.3.763
Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
K. C. Evans (1995)
10.1016/0092-8674(95)90320-8
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation
M. Kounnas (1995)
10.1073/PNAS.92.21.9480
Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line.
D. Holtzman (1995)
10.1006/exnr.1995.1080
Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress
T. Oda (1995)
10.1074/JBC.270.16.9039
Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*)
M. LaDu (1995)
10.1074/jbc.270.45.27063
Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*)
S. Bellosta (1995)
10.1016/0197-4580(96)00112-1
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
J. Ma (1996)
10.1111/j.1749-6632.1996.tb34431.x
Amyloid β‐Protein, APOE Genotype and Head Injury
J. A. R. Nicoll (1996)
10.1074/JBC.271.8.4077
Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*)
Y. Kuo (1996)
10.1038/ng0996-55
Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides
M. Miyata (1996)
10.1074/JBC.271.14.8373
Human Apolipoprotein E Receptor 2
D. Kim (1996)
Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides.
J. Ma (1996)
10.1073/PNAS.93.9.4229
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
B. Zlokovic (1996)
10.1097/00005072-199604000-00012
Expression of the Very Low‐Density Lipoprotein Receptor (VLDL‐r), an Apolipoprotein‐E Receptor, in the Central Nervous System and in Alzheimer's Disease
Richard H. Christie (1996)
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease
Y. M. Kuo (1996)
10.1212/WNL.49.1.56
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease
D. Kang (1997)
10.1006/exnr.1996.6373
Nitric Oxide Synthase in Reactive Astrocytes Adjacent to β-Amyloid Plaques
M. N. Wallace (1997)
10.1046/J.1471-4159.1997.68020760.X
Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures
P. Puttfarcken (1997)
10.1001/JAMA.277.10.818
Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
A. Slooter (1997)
10.1046/j.1471-4159.1997.69051904.x
α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein
M. Narita (1997)
10.1021/BI9626362
Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
S. Aleshkov (1997)
10.1016/S0165-5728(97)00021-0
Apolipoprotein E suppresses glial cell secretion of TNFα
D. Laskowitz (1997)
10.1523/JNEUROSCI.17-08-02653.1997
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Mark A. Smith (1997)
10.1038/1243
Alpha-2 macroglobulin is genetically associated with Alzheimer disease
D. Blacker (1998)
Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation.
J. Hu (1998)
10.1111/j.1750-3639.1998.tb00136.x
Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression
W.S.T. Griffin (1998)
10.1523/JNEUROSCI.18-09-03261.1998
Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins
Y. Sun (1998)
10.1042/BJ3360381
Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.
L. Goretzki (1998)
10.1097/00041433-199804000-00012
Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family.
G. Bu (1998)
10.1523/JNEUROSCI.18-01-00195.1998
Isoform-Specific Effect of Apolipoprotein E on Cell Survival and β-Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures
J. Jordán (1998)
Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.
J. Hu (1998)
10.1046/j.1471-4159.1998.70052070.x
Nascent Astrocyte Particles Differ from Lipoproteins in CSF
M. LaDu (1998)
10.1074/JBC.273.50.33556
Interaction of Cytosolic Adaptor Proteins with Neuronal Apolipoprotein E Receptors and the Amyloid Precursor Protein*
M. Trommsdorff (1998)
10.1046/j.1471-4159.1998.70041458.x
β‐Amyloid Peptides Increase the Binding and Internalization of Apolipoprotein E to Hippocampal Neurons
U. Beffert (1998)
10.1073/PNAS.95.11.6448
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
M. Lambert (1998)
10.1016/S0006-8993(97)01318-8
Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release
J. Hu (1998)
10.1046/j.1471-4159.1998.71041626.x
Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation
Jingru Hu (1998)
10.1097/00001756-199803090-00010
Endogenous apolipoprotein E suppresses LPS‐stimulated microglial nitric oxide production
D. Laskowitz (1998)
Low-density-lipoprotein-receptorrelated protein (LRP) interacts with a GTP-binding protein
L. Goretzki (1998)
high avidity binding to  - amyloid and increased frequency of type 4 allele in late - onset familial Alzheimer disease
Y. Sun (1998)
10.1016/S0168-0102(99)00075-9
Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain
S. Fujita (1999)
10.1016/S0092-8674(00)80782-5
Reeler/Disabled-like Disruption of Neuronal Migration in Knockout Mice Lacking the VLDL Receptor and ApoE Receptor 2
M. Trommsdorff (1999)
10.1016/S0306-4522(98)00489-8
Expression and alternate splicing of apolipoprotein E receptor 2 in brain
A. Clatworthy (1999)
10.1111/j.1749-6632.2000.tb06365.x
Lipoproteins in the Central Nervous System
M. LaDu (2000)
10.1523/JNEUROSCI.20-22-08401.2000
Neuronal Apoptosis by Apolipoprotein E4 through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases
Y. Hashimoto (2000)
10.1074/jbc.M000602200
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures*
M. LaDu (2000)



This paper is referenced by
10.1016/j.brainresbull.2021.01.014
Daily oscillation of cognitive factors is modified in the temporal cortex of an amyloid β(1-42)-induced rat model of Alzheimer’s disease
Cinthia Coria-Lucero (2021)
10.1002/glia.23974
Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation
M. F. Lanfranco (2021)
10.1016/j.mad.2021.111462
Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures
M. Lennol (2021)
10.1016/j.pneurobio.2021.102032
ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer’s disease
Zhi-Hao Wang (2021)
10.1038/s41380-020-0824-3
MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s disease pathogenesis
(2020)
10.3389/fphys.2020.00683
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
D. Liccardo (2020)
10.3389/fnmol.2019.00234
The Dual Role of Kinin/Kinin Receptors System in Alzheimer’s Disease
Bingyuan Ji (2019)
10.1063/1.5085515
New APOE-related therapeutic options for Alzheimer’s disease
Ziying Li (2019)
10.1007/s12035-018-1237-z
APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
M. Uddin (2018)
Chapter 5 Lipids and Lipoproteins in Alzheimer ’ s Disease
Sophie K. Stukas (2018)
10.1016/j.neuint.2018.08.010
Palmitate treated-astrocyte conditioned medium contains increased glutathione and interferes in hypothalamic synaptic network in vitro
Ariadne de Almeida Branco Oliveira (2018)
10.1016/j.mcn.2018.03.015
Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide
L. Montoliu-Gaya (2018)
10.14288/1.0368620
The role of lipoproteins on selected functions relevant to Alzheimer's Disease in human brain perivascular cells
Sonja K. Soo (2018)
Title: Targeted delivery of rosmarinic acid across the blood–brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide)
Y. Kuo (2017)
10.1016/j.ncl.2017.01.001
Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.
B. González (2017)
10.3389/fnagi.2017.00195
16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain
D. C. Emery (2017)
10.1016/j.ijpharm.2017.05.039
Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
Y. Kuo (2017)
10.1016/j.neuron.2017.11.013
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu (2017)
10.3233/JAD-160133
Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
Evan Dorey (2017)
10.1016/j.brainres.2017.01.033
Daily rhythms of cognition-related factors are modified in an experimental model of Alzheimer’s disease
Lorena S. Navigatore-Fonzo (2017)
10.2147/CIA.S143632
Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis
Yunxia Jiang (2017)
10.1016/j.chembiol.2016.10.015
Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes.
Gina M. Finan (2016)
10.1016/j.neubiorev.2015.08.021
Obesity and sex interact in the regulation of Alzheimer's disease
V. Moser (2016)
10.1038/srep29364
Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s disease in vitro
S. Ghura (2016)
10.1186/s12974-016-0772-7
LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways
Longyu Yang (2016)
10.2147/IJN.S123442
Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus
Y. Kuo (2016)
10.1038/srep33615
Absence of apolipoprotein E protects mice from cerebral malaria
F. A. Kassa (2016)
10.1007/s12031-016-0839-z
The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update
Laura Mahoney-Sánchez (2016)
10.1021/acs.jproteome.6b00003
High-Throughput LC-MS/MS Proteomic Analysis of a Mouse Model of Mesiotemporal Lobe Epilepsy Predicts Microglial Activation Underlying Disease Development.
V. Bitsika (2016)
10.1016/j.neuropharm.2016.04.032
Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice
Xilin Zhang (2016)
10.5772/59808
Lipids and Lipoproteins in Alzheimer’s Disease
Sophie Stukas (2015)
10.1016/J.NRL.2012.12.007
Astrocitos en las enfermedades neurodegenerativas (I): función y caracterización molecular
T. Guillamón-Vivancos (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar